BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lang A, Sakhnini E, Fidder HH, Maor Y, Bar-Meir S, Chowers Y. Somatostatin inhibits pro-inflammatory cytokine secretion from rat hepatic stellate cells. Liver Int 2005;25:808-16. [PMID: 15998432 DOI: 10.1111/j.1478-3231.2005.01057.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Van Op den Bosch J, Adriaensen D, Van Nassauw L, Timmermans JP. The role(s) of somatostatin, structurally related peptides and somatostatin receptors in the gastrointestinal tract: a review. Regul Pept. 2009;156:1-8. [PMID: 19362110 DOI: 10.1016/j.regpep.2009.04.003] [Cited by in Crossref: 69] [Cited by in F6Publishing: 62] [Article Influence: 5.8] [Reference Citation Analysis]
2 Koumarianou A, Alexandraki KI, Wallin G, Kaltsas G, Daskalakis K. Pathogenesis and Clinical Management of Mesenteric Fibrosis in Small Intestinal Neuroendocine Neoplasms: A Systematic Review. J Clin Med. 2020;9. [PMID: 32521677 DOI: 10.3390/jcm9061777] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
3 Vindeløv SD, Hartoft-Nielsen ML, Rasmussen ÅK, Bendtzen K, Kosteljanetz M, Andersson AM, Feldt-Rasmussen U. Interleukin-8 production from human somatotroph adenoma cells is stimulated by interleukin-1β and inhibited by growth hormone releasing hormone and somatostatin. Growth Horm IGF Res 2011;21:134-9. [PMID: 21658592 DOI: 10.1016/j.ghir.2011.03.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
4 Rubio A, Ávila J, de Lecea L. Cortistatin as a therapeutic target in inflammation. Expert Opinion on Therapeutic Targets 2006;11:1-9. [DOI: 10.1517/14728222.11.1.1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
5 Klironomos S, Notas G, Sfakianaki O, Kiagiadaki F, Xidakis C, Kouroumalis E. Octreotide modulates the effects on fibrosis of TNF-α, TGF-β and PDGF in activated rat hepatic stellate cells. Regul Pept. 2014;188:5-12. [PMID: 24291170 DOI: 10.1016/j.regpep.2013.11.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
6 Park O, Jeong WI, Wang L, Wang H, Lian ZX, Gershwin ME, Gao B. Diverse roles of invariant natural killer T cells in liver injury and fibrosis induced by carbon tetrachloride. Hepatology 2009;49:1683-94. [PMID: 19205035 DOI: 10.1002/hep.22813] [Cited by in Crossref: 127] [Cited by in F6Publishing: 121] [Article Influence: 10.6] [Reference Citation Analysis]
7 Khumbatta M, Firozgary B, Tweardy DJ, Weinstock J, Firozgary G, Bhatena Z, Bulsara T, Siller R, Robinson P. Somatostatin negatively regulates parasite burden and granulomatous responses in cysticercosis. Biomed Res Int 2014;2014:247182. [PMID: 25530957 DOI: 10.1155/2014/247182] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
8 Al-Shorbagy MY, Nassar NN. Octreotide ameliorates inflammation and apoptosis in acute and kindled murine PTZ paradigms. Naunyn Schmiedebergs Arch Pharmacol 2017;390:61-8. [PMID: 27695956 DOI: 10.1007/s00210-016-1303-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
9 Antoniu SA. Somatostatin analogs for idiopathic pulmonary fibrosis therapy. Expert Opin Investig Drugs 2008;17:1137-40. [PMID: 18549349 DOI: 10.1517/13543784.17.7.1137] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
10 Herszényi L, Mihály E, Tulassay Z. Somatostatin and gastrointestinal tract. Clinical experiences. Orv Hetil. 2013;154:1535-1540. [PMID: 24058098 DOI: 10.1556/oh.2013.29721] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
11 Blažević A, Hofland J, Hofland LJ, Feelders RA, de Herder WW. Small intestinal neuroendocrine tumours and fibrosis: an entangled conundrum. Endocr Relat Cancer 2018;25:R115-30. [PMID: 29233841 DOI: 10.1530/ERC-17-0380] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 3.8] [Reference Citation Analysis]
12 Armani C, Catalani E, Balbarini A, Bagnoli P, Cervia D. Expression, pharmacology, and functional role of somatostatin receptor subtypes 1 and 2 in human macrophages. J Leukoc Biol. 2007;81:845-855. [PMID: 17148691 DOI: 10.1189/jlb.0606417] [Cited by in Crossref: 83] [Cited by in F6Publishing: 79] [Article Influence: 5.5] [Reference Citation Analysis]
13 Friedman SL. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev 2008;88:125-72. [PMID: 18195085 DOI: 10.1152/physrev.00013.2007] [Cited by in Crossref: 1682] [Cited by in F6Publishing: 1621] [Article Influence: 129.4] [Reference Citation Analysis]
14 Schaalan MF, Nassar NN. Effects of Octreotide in Chronically Mild Stressed Rats: Possible Role of Immune and Oxidative Stress Pathways. Neurochem Res 2011;36:1717-23. [DOI: 10.1007/s11064-011-0486-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
15 Zhang C, An R, Bao Y, Meng X, Wang T, Sun H, Pan F, Zhang C. Inhibitory effects of octreotide on the progression of hepatic fibrosis via the regulation of Bcl-2/Bax and PI3K/AKT signaling pathways. International Immunopharmacology 2019;73:515-26. [DOI: 10.1016/j.intimp.2019.05.055] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
16 Schubert ML, Rehfeld JF. Gastric Peptides-Gastrin and Somatostatin. Compr Physiol 2019;10:197-228. [PMID: 31853955 DOI: 10.1002/cphy.c180035] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
17 Wang BB, Cheng JY, Gao HH, Zhang Y, Chen ZN, Bian H. Hepatic stellate cells in inflammation-fibrosis-carcinoma axis. Anat Rec (Hoboken). 2010;293:1492-1496. [PMID: 20652939 DOI: 10.1002/ar.21173] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
18 Lacoste B, Raymond VA, Lapierre P, Bilodeau M. Protection against Acute Hepatocellular Injury Afforded by Liver Fibrosis Is Independent of T Lymphocytes. PLoS One. 2016;11:e0165360. [PMID: 27792745 DOI: 10.1371/journal.pone.0165360] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
19 Günther T, Tulipano G, Dournaud P, Bousquet C, Csaba Z, Kreienkamp HJ, Lupp A, Korbonits M, Castaño JP, Wester HJ, Culler M, Melmed S, Schulz S. International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature. Pharmacol Rev 2018;70:763-835. [PMID: 30232095 DOI: 10.1124/pr.117.015388] [Cited by in Crossref: 70] [Cited by in F6Publishing: 62] [Article Influence: 35.0] [Reference Citation Analysis]
20 Taquet N, Dumont S, Vonesch JL, Hentsch D, Reimund JM, Muller CD. Differential between protein and mRNA expression of CCR7 and SSTR5 receptors in Crohn's disease patients. Mediators Inflamm 2009;2009:285812. [PMID: 20150960 DOI: 10.1155/2009/285812] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
21 Long D, Lu J, Luo L, Guo Y, Li C, Wu W, Shan J, Li L, Li S, Li Y. Effects of octreotide on activated pancreatic stellate cell-induced pancreas graft fibrosis in rats. J Surg Res. 2012;176:248-259. [PMID: 21816420 DOI: 10.1016/j.jss.2011.06.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
22 Gordin D, Forsblom C, Rönnback M, Parkkonen M, Wadén J, Hietala K, Groop P. Acute hyperglycaemia induces an inflammatory response in young patients with type 1 diabetes. Annals of Medicine 2009;40:627-33. [DOI: 10.1080/07853890802126547] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
23 Clement D, Ramage J, Srirajaskanthan R. Update on Pathophysiology, Treatment, and Complications of Carcinoid Syndrome. J Oncol 2020;2020:8341426. [PMID: 32322270 DOI: 10.1155/2020/8341426] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
24 Hessheimer AJ, Martínez de la Maza L, Adel Al Shwely F, Espinoza AS, Ausania F, Fondevila C. Somatostatin and the "Small-For-Size" Liver. Int J Mol Sci 2019;20:E2512. [PMID: 31121844 DOI: 10.3390/ijms20102512] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
25 Zhang C, Liu X, Sun H, Meng X, Bao Y, Zhang H, Pan F, Zhang C. Octreotide attenuates hepatic fibrosis and hepatic stellate cells proliferation and activation by inhibiting Wnt/β-catenin signaling pathway, c-Myc and cyclin D1. International Immunopharmacology 2018;63:183-90. [DOI: 10.1016/j.intimp.2018.08.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]